谷氨酰胺联合四君子汤可能优于单用谷氨酰胺治疗5-FU肠黏膜炎
该研究在小鼠模型中探索谷氨酰胺与四君子汤组成的复方胶囊(G-SJZ)对5-氟尿嘧啶(5-Fu)诱导肠黏膜炎的作用。结果显示G-SJZ预处理可减轻体重下降和腹泻严重程度,改善组织病理损伤及紧密连接蛋白表达,且效果优于等剂量单用谷氨酰胺。
要点
- G-SJZ预处理可改善5-Fu小鼠体重下降和腹泻严重程度
- G-SJZ减轻肠黏膜组织病理损伤及绒毛隐窝结构破坏
- G-SJZ保护作用优于等剂量单用谷氨酰胺
核心结论
- 谷氨酰胺联合四君子汤的复方胶囊(G-SJZ)对5-Fu诱导的小鼠肠黏膜炎具有保护作用,且可能优于单用谷氨酰胺。
研究设计与样本
- 研究采用5-氟尿嘧啶(5-Fu)诱导的小鼠肠黏膜炎模型,比较G-SJZ与等剂量单用谷氨酰胺的效应。
主要发现
- G-SJZ预处理改善5-Fu连续注射小鼠的体重下降和腹泻严重程度。
- G-SJZ逆转5-Fu引起的肠黏膜组织病理损伤、绒毛和隐窝结构破坏及循环肠损伤标志物升高。
- G-SJZ的保护作用伴随紧密连接蛋白免疫组化表达的调节。
- 等剂量单用谷氨酰胺也显示保护作用,但不如G-SJZ强。
临床怎么用
- 对于5-Fu相关肠黏膜炎,可考虑谷氨酰胺联合四君子汤的复方制剂而非单用谷氨酰胺。
局限性
- 研究仅在小鼠模型中进行,确切机制仍需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Intestinal mucositis is a common toxicity of many anti-neoplastic therapies that negatively influences health, the quality of life, economic outcomes, and even the success of cancer treatment. Unfortunately, there is presently no optimal medicine that is able to effectively manage this condition. l-glutamine is one of the most frequently used agent in practice among the limited treatment choices due to its safety and inexpensiveness despite there being a lack of evidence. Previous studies indicated that l-glutamine may alleviate mucositis and mucosal atrophy but failed to improve patients' macroscopic conditions, such as the occurrence of diarrhea. A compound glutamine capsule (G-SJZ), composed of l-glutamine and the traditional Chinese herbal formula Si-Jun-Zi-Tang, has been used in China for 23 years to treat many types of gastrointestinal diseases, including gastrointestinal reactions induced by radiotherapy and chemotherapy. However, the exact effect of G-SJZ on intestinal mucositis is unclear, and moreover, whether l-glutamine combined with Si-Jun-Zi-Tang is more effective than l-glutamine alone have not been studied. In the current study, we explored the effects of G-SJZ and l-glutamine in a mouse model of intestinal mucositis induced by 5-fluorouracil (5-Fu). The results revealed that pretreatment with G-SJZ ameliorated the physical manifestations of weight loss and the severity of diarrhea following continuous 5-Fu injections in mice. Likewise, the histopathological damage and the destruction of villus and crypt structures in the intestinal mucosa as well as the increase in circulating intestinal injury markers caused by 5-Fu were reversed with G-SJZ pretreatment. Furthermore, the protective effect of G-SJZ was accompanied by modulations in the immunohistochemical expression of tight junction proteins. Interestingly, although treatment with a dose of l-glutamine alone that was equivalent to the dose in G-SJZ also showed a protective effect, it did not appear to be as strong as treatment with G-SJZ. Si-Jun-Zi-Tang in G-SJZ may compensate for the deficiencies of l-glutamine in this model which seems not to be related to the regulation of tight junction proteins. Our study is the first to suggest that the combined use of l-glutamine and Si-Jun-Zi-Tang might be more effective than l-glutamine alone despite exact mechanism still needs further study. Because of the limited number of therapeutic agents, G-SJZ is likely to be a preferable choice for intestinal mucositis.
引用
- Qu L, Tan W, Yang J, et al. Combination Compositions Composed of l-Glutamine and Si-Jun-Zi-Tang Might Be a Preferable Choice for 5-Fluorouracil-Induced Intestinal Mucositis: An Exploration in a Mouse Model. Front Pharmacol. 2020. PMID: 32625099. doi:10.3389/fphar.2020.00918
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。